We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ChanTest Acquires Applied Cell Sciences
News

ChanTest Acquires Applied Cell Sciences

ChanTest Acquires Applied Cell Sciences
News

ChanTest Acquires Applied Cell Sciences

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ChanTest Acquires Applied Cell Sciences"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ChanTest, a provider of ion channel testing services and validated cell lines, announced that it has acquired Rockville, Maryland-based Applied Cell Sciences. ACS is a contract research organization (CRO) specializing in GPCRs.

The combined company will maintain both facilities in Rockville and Cleveland. Jesse Baumgold, Ph.D., who has led ACS since its inception in 2004, has been named ChanTest vice president of business development and product strategy. He will continue to direct the company's operations in Rockville. Terms of the acquisition were not disclosed.

Applied Cell Sciences products and services include optimized GPCR functional analysis tools, high-throughput screening reagents and reagent-development services, stable GPCR cell lines, cell membranes for binding studies, cryopreserved growth-arrested cells, custom cell line construction, gene-to-screen cell line construction and validation, large-scale cell cryopreservation, and specialized screening services. Going forward, ACS products and services will be marketed under the ChanTest name.

ChanTest's acquisition of ACS has been executed to ensure continuity of management, quality science, and service to clients. Customers are encouraged to contact their existing ChanTest or ACS representative to learn about the combined company's expanded portfolio of cell-based assays and reagents, new division-arrested cell lines, membrane preparations, and large cell line scale-up capabilities.
Advertisement